Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.4960
+0.0150 (3.12%)
Jul 3, 2026, 5:29 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 163.07 million as of July 2, 2026. Its market cap has increased by 55.07% in one year.
Market Cap
163.07M
Enterprise Value
242.88M
Revenue
31.83M
Ranking
n/a
PE Ratio
1.91
Stock Price
0.50
Market Cap Chart
Since October 30, 2015, Nanologica AB's market cap has increased from 73.54M to 163.07M, an increase of 121.73%. That is a compound annual growth rate of 7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 163.07M | 136.58% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 222.54M |
| Elicera Therapeutics AB | 195.54M |
| IRLAB Therapeutics AB | 195.41M |
| Initiator Pharma | 190.98M |
| Xintela AB | 175.70M |
| Diamyd Medical AB | 168.93M |
| Active Biotech AB | 149.07M |
| NextCell Pharma AB | 122.60M |